pfizer inc (PFE:New York)
Mace L. Rothenberg M.D.
Chief Medical Officer and Senior Vice President of Clinical Development & Medical Affairs - Oncology Business Unit, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
Dr. Mace L. Rothenberg M.D. has been Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs for Oncology Business Unit at Pfizer Inc. since January 2014 and October 2008 respectively. Dr. Rothenberg is responsible for overseeing clinical research and development activities and post-marketing evaluation and monitoring for all oncology products. He also coordinates evaluation of anticancer compounds that emerge from Pfizer's new Biotechnology ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*There is no Board Members Memberships data available.
NYU Elaine A. and Kenneth G. Langone Medical Center
Unknown/Other Education 1985
The University of Pennsylvania
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Paul Bulcke B.E.||Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee|
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.3M||Compensation as of Fiscal Year 2014.|